vTv Therapeutics Inc. (VTVT)
vTv Therapeutics Inc. reported revenue of 0 USD for the quarter ending 30 June 2026.
Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
filled in.
Quarters are the company's own, counted from its financial
year ending 12-31.
Amounts in USD.
The same series drawn ›
As last reported
The newest period the filing supports for each figure, in USD.
| Figure | Period | Amount | Year on year |
| Revenue |
Q2 '26 · ending 30 June 2026 |
0 |
— |
| Operating Income |
Q2 '26 · ending 30 June 2026 |
-13.9M |
— |
| Net Income |
Q2 '26 · ending 30 June 2026 |
-13.1M |
— |
| Operating Cash Flow |
Q2 '26 · ending 30 June 2026 |
-11.4M |
— |
| Free Cash Flow |
Q4 '23 · ending 31 December 2023 |
-2.9M |
— |
Revenue and profit by financial year
As filed, in USD. A year the filing does not support is not listed.
| Year | Ending |
Revenue | Operating Income | Net Income | Free Cash Flow |
| 2025 | 2025-12-31 |
0 | -32.8M | -27M | — |
| 2024 | 2024-12-31 |
1M | -24.2M | -18.5M | -25.3M |
| 2023 | 2023-12-31 |
0 | -25.5M | -20.2M | -19.1M |
| 2022 | 2022-12-31 |
2M | -22.5M | -19.2M | -16M |
| 2021 | 2021-12-31 |
4M | -21.7M | -13M | -19.3M |
| 2020 | 2020-12-31 |
6.4M | -11.9M | -8.5M | -18M |
| 2019 | 2019-12-31 |
2.8M | -20.9M | -13M | -23.1M |
| 2018 | 2018-12-31 |
12.4M | -19.8M | -7.9M | -26.9M |
| 2017 | 2017-12-31 |
291K | -50.7M | -16.1M | -44.6M |
| 2016 | 2016-12-31 |
634K | -55M | -16.4M | -48.3M |
Every period
Revenue Quarterly
| Period | Ending | Revenue |
| Q2 '26 | 2026-06-30 | 0 |
| Q1 '26 | 2026-03-31 | 36.8M |
| Q4 '25 | 2025-12-31 | 0 |
| Q3 '25 | 2025-09-30 | 0 |
| Q2 '25 | 2025-06-30 | 0 |
| Q1 '25 | 2025-03-31 | 0 |
| Q4 '24 | 2024-12-31 | 17K |
| Q3 '24 | 2024-09-30 | 0 |
| Q2 '24 | 2024-06-30 | 0 |
| Q1 '24 | 2024-03-31 | 1M |
| Q4 '23 | 2023-12-31 | 0 |
| Q3 '23 | 2023-09-30 | 0 |
| Q2 '23 | 2023-06-30 | 0 |
| Q1 '23 | 2023-03-31 | 0 |
| Q4 '22 | 2022-12-31 | 9K |
| Q3 '22 | 2022-09-30 | 0 |
| Q2 '22 | 2022-06-30 | 9K |
| Q1 '22 | 2022-03-31 | 2M |
| Q4 '21 | 2021-12-31 | 9K |
| Q3 '21 | 2021-09-30 | 3M |
Operating Income Quarterly
| Period | Ending | Operating Income |
| Q2 '26 | 2026-06-30 | -13.9M |
| Q1 '26 | 2026-03-31 | 23.3M |
| Q4 '25 | 2025-12-31 | -7.9M |
| Q3 '25 | 2025-09-30 | -10.7M |
| Q2 '25 | 2025-06-30 | -7.7M |
| Q1 '25 | 2025-03-31 | -6.5M |
| Q4 '24 | 2024-12-31 | -4.9M |
| Q3 '24 | 2024-09-30 | -6.5M |
| Q2 '24 | 2024-06-30 | -7.2M |
| Q1 '24 | 2024-03-31 | -5.6M |
| Q4 '23 | 2023-12-31 | -4.7M |
| Q3 '23 | 2023-09-30 | -5.4M |
| Q2 '23 | 2023-06-30 | -8M |
| Q1 '23 | 2023-03-31 | -7.4M |
| Q4 '22 | 2022-12-31 | -6.3M |
| Q3 '22 | 2022-09-30 | -5.7M |
| Q2 '22 | 2022-06-30 | -4M |
| Q1 '22 | 2022-03-31 | -6.5M |
| Q4 '21 | 2021-12-31 | -11.1M |
| Q3 '21 | 2021-09-30 | -1.6M |
Net Income Quarterly
| Period | Ending | Net Income |
| Q2 '26 | 2026-06-30 | -13.1M |
| Q1 '26 | 2026-03-31 | 24.1M |
| Q4 '25 | 2025-12-31 | -7.1M |
| Q3 '25 | 2025-09-30 | -8.7M |
| Q2 '25 | 2025-06-30 | -6M |
| Q1 '25 | 2025-03-31 | -5.1M |
| Q4 '24 | 2024-12-31 | -3.6M |
| Q3 '24 | 2024-09-30 | -4.8M |
| Q2 '24 | 2024-06-30 | -5.2M |
| Q1 '24 | 2024-03-31 | -4.9M |
| Q4 '23 | 2023-12-31 | -3.5M |
| Q3 '23 | 2023-09-30 | -6.7M |
| Q2 '23 | 2023-06-30 | -5.6M |
| Q1 '23 | 2023-03-31 | -4.5M |
| Q4 '22 | 2022-12-31 | -4.7M |
| Q3 '22 | 2022-09-30 | -4.3M |
| Q2 '22 | 2022-06-30 | -3.2M |
| Q1 '22 | 2022-03-31 | -7M |
| Q4 '21 | 2021-12-31 | -7.1M |
| Q3 '21 | 2021-09-30 | -1.1M |
Operating Cash Flow Quarterly
| Period | Ending | Operating Cash Flow |
| Q2 '26 | 2026-06-30 | -11.4M |
| Q1 '26 | 2026-03-31 | 9.2M |
| Q4 '25 | 2025-12-31 | -9.3M |
| Q3 '25 | 2025-09-30 | -5.2M |
| Q2 '25 | 2025-06-30 | -5.1M |
| Q1 '25 | 2025-03-31 | -5.7M |
| Q4 '24 | 2024-12-31 | -4.8M |
| Q3 '24 | 2024-09-30 | -6.4M |
| Q2 '24 | 2024-06-30 | -6.7M |
| Q1 '24 | 2024-03-31 | -7.3M |
| Q4 '23 | 2023-12-31 | -2.9M |
| Q3 '23 | 2023-09-30 | -4.8M |
| Q2 '23 | 2023-06-30 | -6.2M |
| Q1 '23 | 2023-03-31 | -5.2M |
| Q4 '22 | 2022-12-31 | -6.9M |
| Q3 '22 | 2022-09-30 | -8.8M |
| Q2 '22 | 2022-06-30 | 706K |
| Q1 '22 | 2022-03-31 | -1M |
| Q4 '21 | 2021-12-31 | -6.4M |
| Q3 '21 | 2021-09-30 | -3.6M |
Free Cash Flow Quarterly
Operating cash flow minus capital expenditure.
| Period | Ending | Free Cash Flow |
| Q4 '23 | 2023-12-31 | -2.9M |
| Q3 '23 | 2023-09-30 | -4.8M |
| Q4 '22 | 2022-12-31 | -6.9M |
| Q3 '22 | 2022-09-30 | -8.8M |
| Q4 '21 | 2021-12-31 | -6.4M |
| Q3 '21 | 2021-09-30 | -3.6M |
| Q4 '18 | 2018-12-31 | -5.9M |
| Q4 '17 | 2017-12-31 | -6.3M |
| Q3 '17 | 2017-09-30 | -11.8M |
| Q2 '17 | 2017-06-30 | -12.6M |
| Q1 '17 | 2017-03-31 | -13.9M |
| Q4 '16 | 2016-12-31 | -11.4M |
| Q3 '16 | 2016-09-30 | -12.7M |
| Q4 '15 | 2015-12-31 | -9M |
| Q3 '15 | 2015-09-30 | -9.8M |
| Q2 '15 | 2015-06-30 | -8.8M |
| Q1 '15 | 2015-03-31 | -9.4M |